Specific Systems of Treatment
nated flesh of fowl and other animals.
Livingston said she found a large degree of infection with Progenitor cryptocides in chick- ens (ibid.).
By the early 1950s, she had not yet begun to treat cancer in animals or man with any special kind of treatment. But, in that decade when che- motherapy was becoming the method most pre- ferred by the big cancer organizations, she began to be regarded with suspicion by those leading can- cer institutes. Cornelius P. “Dusty” Rhodes, of the NCI, led out in derogatory comments about the work carried on by Livingston and her associates, which included curtailing her sources of research money.
In 1968, something called the “Livingston Vac- cine,” was included in the ACS’s Unproven Meth- ods book. After careful investigation of the vac- cine, the ACS had concluded that it had no objec- tive benefits in the treatment of cancer.
Yet no such vaccine existed! Any genuine “in-
vestigation” would have disclosed the fact. Up to that time, Livingston still had not treated cancer with any unorthodox method, and she had no “vac- cine.”
But other physicians were treating with an anti- Progenitor cryptocides vaccine. Some of the pa- tients survived for more than a year and a half.
This false report about her having a “Livingston Vaccine” goaded her into action, and she began more vigorous research work. In 1968, at the Biomed Laboratory in San Diego, the “cancer microbe” was filtered, put into tissue culture,— and produced degeneration of cells, under cer- tain conditions, and proliferation of cells in oth- ers.
It was also discovered that the cancer bac- teria were sensitive to certain chemotherapy when outside cells, but hardly at all when in- side human cells. That does not speak well for chemotherapy, which is generally thought to poi- son every kind of cell it comes in contact with.
In 1969, she and her husband opened the Livingston Medical Clinic, in San Diego, and be- gan immunization treatment of cancer patients.
“My studies had led me to the conclusion that cancer is an immune deficiency disease based on infection by a definite etiological agent, the Progenitor cryptocides. On the basis of treating an immune deficiency in man, we began to ac- cept cancer patients.”—Virginia Livingston, A New Breakthrough, 1972. This treatment included a vaccine to fight the microbe, a health-food diet, and the adop- tion of a relaxed way of life. Thus, her program was more comprehensive than that of many other
In 1972, one of her associates, Dr. Owen Wheeler, asked her to treat him solely by immuni- zation. He completely recovered and, when Livingston’s husband (Dr. A.M. Livingston) died, she married Wheeler.
In 1970, working at the University of San Di- ego, she showed that the “cancer microbe” pro- duced an antibiotic (actinomycin) as well as toxic material which increased the frequency of cancer in mice.
Using a dark-field microscope, she was able to describe the entire life cycle of this complicated, ever-changing germ. (It was at this time that she named the microbe.)
That same year, Livingston made a remark- able discovery: Progenitor cryptocides was able to produce a human hormone. Never before, had a germ of any kind been known to manufacture a human hormone! Further research into this par- ticular one (human choriogonadotrophin; HCG) revealed that it has long been known to be present in greater amounts in cancer patients. HCG is a human growth hormone!
(That recalls to mind the research of Dr. Wachtel, who noted that injections of an extract of the human anterior lobe of the pituitary, which produces growth hormones, would significantly in- crease the size of cancer tissue.)
Oddly enough, HCG is present in human sperm and is needed for growth from the very beginning of human life.
Two years later, researchers at Princeton Uni- versity confirmed that HCG could be made by a bacteria (H. Cohen and A. Strampp, “Bacterial Synthesis of a Substance Similar to Huan Chori- onic Gonadotrophin,” Proceedings of the Society for Experimental Biology and Medicines, July 1976).
In 1978, it was confirmed again, this time by H.F. Acevedo of the W.H. Singer Memorial Research Institute in Pittsburg, that Progenitor cryptocides produced that human growth hormone. Acevedo felt that a number of other bacteria in cancer pa- tients also produced HCG as well. Commenting on Livingston’s findings, Acevedo wrote:
“The impact of these findings in the fields of oncology, bacteriology, epidemiology, genetics and molecular biology is so great that a detailed description will be beyond the scope of this com- munication . . It is apparent that his phenom- enon exposes the need for a new approach to the analysis as well as to our current concepts of cancer.”—Hernan F. Acevedo, Cancer 41:1217- 29, 1978. Probably one of Livingston’s most important